December 13, 2024 03:44 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal
MSN Group launches urinary incontinence drug

MSN Group launches urinary incontinence drug

Mar 23, 2023, at 12:02 am

Kolkata: MSN Labs, a research-based and fully-integrated global pharmaceutical company based out of Hyderabad, announced the launch of Fesobig, a bio-equivalent generic version of Fesoterodine Fumarate.

MSN Labs launches Posaconazole to treat Black Fungus

MSN Labs launches Posaconazole to treat Black Fungus

May 22, 2021, at 12:25 am

Kolkata/IBNS: Drugmaker MSN Laboratories Pvt. Ltd. (MSN) on Friday introduced Posaconazole under the brand name PosaOne, a triazole antifungal agent, for treating mucormycosis or Black Fungus in patients, especially those recovering from Covid19.